Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG4.L Regulatory News (MIG4)

  • There is currently no data for MIG4

Interim Management Statement - replacement

16 Nov 2023 14:00

RNS Number : 7321T
Mobeus Income & Growth 4 VCT PLC
16 November 2023

The following amendment has been made to the 'Interim Management Statement' announcement released on 15 November 2023 at 15:00 under RNS No 5916T.

The NAV per share has increased by 2.13 pence in the quarter.

All other details remain unchanged.

The full amended text is shown below.

MOBEUS INCOME & GROWTH 4 VCT PLC

("the Company")

LEI: 213800IFNJ65R8AQW943

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2023

Mobeus Income & Growth 4 VCT plc presents an Interim Management Statement for the quarter ended 30 September 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30 September 2023

(unaudited)

At 30 June 2023

(unaudited)

Net assets attributable to shareholders

£86.59 million

£84.23 million

Shares in issue

110,556,762

110,556,762

Net asset value (NAV) per share

78.32 pence

76.19 pence

Cumulative dividends paid

158.20 pence

158.20 pence

Cumulative Total return (net asset value basis) per share since inception

236.52 pence

234.39 pence

The NAV per share has increased by 2.13 pence in the quarter (an increase of 2.8% from the NAV per share at 30 June 2023).

INVESTMENT ACTIVITY DURING THE PERIOD

New Investment during the period

On 26 July 2023, the Company completed a new investment of £0.40 million into Mable Therapy Limited, a digital health platform for speech therapy and counselling for children and young adults.

On 3 August 2023, the Company completed a new investment of £0.39 million into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

Further Investments during the period

On 4 July 2023, a follow on equity investment of £0.33 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

On 11 August 2023, a follow on loan investment of £0.13 million was made into Orri Limited, an intensive day care provider for adults with eating disorders.

INVESTMENT ACTIVITY AFTER THE PERIOD END

There has been no activity post-quarter.

SHARE BUYBACK AFTER THE PERIOD END

On 17 October 2023, the Company purchased 525,821 of its own ordinary shares at a price of 66.68 pence per share.

All shares bought back by the Company were subsequently cancelled.

DIVIDEND DECLARED AFTER THE PERIOD END

On 5 October 2023, a second interim dividend of 6.00 pence per share in respect of the year ending 31 December 2023 was declared and was paid on 8 November 2023 to all Shareholders whose names were on the register on 13 October 2023. Payment of this interim dividend has reduced NAV per share (shown above) to 72.32 pence and increased cumulative dividends paid to 164.20 pence per share.

DIVIDEND INVESTMENT SCHEME ("DIS")

On 8 November 2023, 1,515,451 shares were allotted through the DIS during the period at a price of 70.19 pence per share.

Please note that all of the above information is unaudited.

Other than as described above, there were no material events during the period and to the date of this announcement.

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCEADFKFSEDFFA
Date   Source Headline
13th Apr 20231:00 pmRNSDividend Declaration
6th Apr 20237:00 amRNSAnnual Financial Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
1st Mar 20237:00 amRNSTotal Voting Rights
6th Feb 20235:28 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:08 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
22nd Dec 20229:34 amRNSTransaction in Own Shares
14th Dec 20221:15 pmRNSDirectorate Change
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited
28th Nov 202210:30 amRNSTransaction in Own Shares and Total Voting Rights
17th Nov 20227:00 amRNSIssue of Equity and Total Voting Rights
14th Nov 20224:00 pmRNSInterim Management Statement
8th Nov 202212:27 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
7th Nov 20221:20 pmRNSDirector/PDMR Shareholding
7th Nov 20221:12 pmRNSIssue of Equity and Total Voting Rights
3rd Nov 20227:00 amRNSNet Asset Value(s)
17th Oct 20221:22 pmRNSOffer for Subscription – Update
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
12th Oct 20224:02 pmRNSResult of Meeting
10th Oct 202212:00 pmRNSTransaction in Own Shares
5th Oct 20221:50 pmRNSOffers for Subscription and Issue of Prospectus
26th Sep 20229:04 amRNSTransaction in Own Shares
16th Sep 202211:28 amRNSN17/22 – MOBEUS INCOME & GROWTH 4 VCT PLC
15th Sep 20226:46 pmRNSHalf-year Report - Replacement
14th Sep 20223:00 pmRNSFundraising Update, Circular and General Meetings
14th Sep 20227:00 amRNSHalf-year Report
15th Aug 20227:00 amRNSIntention To Launch Joint Offers For Subscription
2nd Aug 20227:00 amRNSNet Asset Value(s)
8th Jul 202211:31 amRNSDirector/PDMR Shareholding
8th Jul 202211:30 amRNSIssue of Equity and Total Voting Rights
13th Jun 20223:15 pmRNSRealisation of investment - Media Business Insight
13th Jun 202210:00 amRNSRealisation of investment - Media Business Insight
19th May 20224:33 pmRNSTransaction in Own Shares
18th May 20227:00 amRNSDividend Declaration
17th May 20223:30 pmRNSResult of AGM
13th May 202212:00 pmRNSInterim Management Statement
14th Apr 20227:00 amRNSTransaction in Own Shares
7th Apr 20227:00 amRNSAnnual Financial Report
9th Mar 20224:30 pmRNSDirector/PDMR Shareholding
9th Mar 20222:30 pmRNSIssue of Equity & Total Voting Rights
4th Mar 20221:15 pmRNSNet Asset Value(s)
3rd Mar 202210:30 amRNSNet Asset Value(s)
23rd Feb 20226:35 pmRNSResult of Meeting
25th Jan 20223:17 pmRNSDirector Declaration
21st Jan 202212:05 pmRNSFundraising Update
20th Jan 20221:16 pmRNSPublication of a Prospectus and Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.